The Elixir Standard
Defining the frontier of clinical longevity through molecular excellence and pharmaceutical-grade bio-activity.
Clinical Futurism in Synthesis
At Elixir Peptide Solutions, we bridge the gap between high-end longevity clinics and sterile pharmaceutical labs. Our catalog—featuring GHK-cu, BPC-157/TB-500, and Retatrutide—is forged under protocols that prioritize molecular stability above all else.
Every sequence, from Sermorelin and IGF-1 to the metabolic power of NAD and Mots-c, undergoes a rigorous multi-stage purification process. We don't just provide compounds; we provide the biological keys to optimized human performance, ensuring that every milligram meets our uncompromising "Obsidian" grade certification.
Molecular Integrity
Groundbreaking research requires a foundation of absolute trust. Our facility utilizes advanced HPLC and Mass Spectrometry to verify the crystalline structure of every peptide batch, ensuring peak bio-availability and zero cross-contamination.
We are committed to absolute transparency in the pursuit of innovation. Our partners receive full structural data and laboratory certificates, empowering researchers to explore the cutting edge of RNA and DNA research with complete confidence.
Restricted to laboratory research use only. Not for human consumption.
GHK-Cu
MW: 340.38 g/mol. Sequence: Gly-His-Lys. Research focus: Copper-mediated cellular signaling and collagen synthesis.
BPC-157
MW: 1419.5 g/mol. Pentadecapeptide sequence. Research focus: Accelerated tendon healing and gastric cytoprotection.
Retatrutide
MW: 4731.33 g/mol. Triple Agonist. Research focus: Synergy of GLP-1, GIP, and Glucagon receptor pathways.
Sermorelin
MW: 3357.88 g/mol. GHRH Analog. Research focus: Pulsatile growth hormone release and pituitary health.
HPL/C & Mass Spec Verified Batches.






